Jarrod Longcor

2021

In 2021, Jarrod Longcor earned a total compensation of $891.4K as Chief Operating Officer and Former Chief Business Officer at Cellectar Biosciences, a 55% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$92,409
Option Awards$414,000
Salary$385,037
Total$891,446

Longcor received $414K in option awards, accounting for 46% of the total pay in 2021.

Longcor also received $92.4K in non-equity incentive plan and $385K in salary.

Rankings

In 2021, Jarrod Longcor's compensation ranked 9,146th out of 12,415 executives tracked by ExecPay. In other words, Longcor earned more than 26.3% of executives.

ClassificationRankingPercentile
All
9,146
out of 12,415
26th
Division
Manufacturing
4,055
out of 5,505
26th
Major group
Chemicals And Allied Products
1,786
out of 2,375
25th
Industry group
Drugs
1,588
out of 2,096
24th
Industry
Pharmaceutical Preparations
1,181
out of 1,546
24th
Source: SEC filing on April 29, 2022.

Longcor's colleagues

We found three more compensation records of executives who worked with Jarrod Longcor at Cellectar Biosciences in 2021.

2021

James Caruso

Cellectar Biosciences

Chief Executive Officer

2021

Dov Elefant

Cellectar Biosciences

Chief Financial Officer

2021

John Friend

Cellectar Biosciences

Chief Medical Officer

News

You may also like